HLB Pharmaceutical Co., Ltd. (KOSDAQ:047920)

Market Cap	257.40B
Revenue (ttm)	36.10B
Net Income (ttm)	472.66M
Shares Out	14.04M
EPS (ttm)	34.13
PE Ratio	544.57
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	108,179
Average Volume	173,497
Open	16,840
Previous Close	16,840
Day's Range	16,690 - 17,200
52-Week Range	16,600 - 33,250
Beta	0.41
RSI	30.55
Earnings Date	n/a

About HLB Pharmaceutical

HLB Pharmaceutical Co., Ltd., a pharmaceutical company, researches and develops peptide drugs in South Korea. The company offers skeletal muscle relaxants, tranquilizers, antihistamines, antihypertensive agents, pain relief, antipruritics, astringents, anti-inflammatories, alimentary system drugs, metabolic drugs, ophthalmic agents, local anesthetics, antiarteriosclerotic agents, expectorants, antipyretics, analgesics, antidiabetic drug, chemotherapeutics, peptic ulcer agents, central nervous system drug, antibiotics, digestives, antacids, dent...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1998
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 047920